Volume | 6,592,037 |
|
|||||
News | - | ||||||
Day High | 17.95 | Low High |
|||||
Day Low | 17.49 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Walgreens Boots Alliance Inc | WBA | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
17.50 | 17.49 | 17.95 | 17.70 | 17.60 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
45,829 | 6,592,037 | US$ 17.75 | US$ 117,033,601 | - | 17.49 - 35.38 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:59:59 | 62 | US$ 17.72 | USD |
Walgreens Boots Alliance (WBA) Options Flow Summary
Walgreens Boots Alliance Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
15.26B | 862.38M | - | 139.08B | -3.08B | -3.57 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Walgreens Boots Alliance News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical WBA Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 17.57 | 18.46 | 17.49 | 17.99 | 8,781,462 | 0.18 | 1.02% |
1 Month | 21.58 | 21.6774 | 17.49 | 18.48 | 13,755,816 | -3.83 | -17.75% |
3 Months | 23.04 | 23.765 | 17.49 | 20.36 | 11,966,112 | -5.29 | -22.96% |
6 Months | 21.71 | 27.05 | 17.49 | 21.94 | 13,127,116 | -3.96 | -18.24% |
1 Year | 34.57 | 35.38 | 17.49 | 24.09 | 11,822,532 | -16.82 | -48.65% |
3 Years | 52.94 | 55.96 | 17.49 | 33.92 | 8,261,109 | -35.19 | -66.47% |
5 Years | 52.72 | 65.00 | 17.49 | 38.37 | 7,462,294 | -34.97 | -66.33% |
Walgreens Boots Alliance Description
Walgreens Boots Alliance is a leading retail pharmacy chain with about 13,000 stores in the U.S. and internationally. Walgreens' core strategy involves brick-and-mortar retail pharmacy locations in high-traffic areas, with nearly 80% of the U.S. population living within 5 miles of a store. Currently, the company has a leading share of the domestic prescription drug market at about 20%. In 2021, the company sold a majority of its Alliance Healthcare wholesale business to AmerisourceBergen for $6.5 billion, doubling down on its core pharmacy efforts and ventures in strategic growth areas in primary care (VillageMD) and digital offerings. The company also has equity stakes in AmerisourceBergen (29%) and Sinopharm Holding Guoda Drugstore (40%). |